Blood based liver evaluation test that uses 7 biomarkers and
advanced technology to determine the general condition of liver
What is LIVERSTAT
LIVERSTAT is a noninvasive tool that uses standard blood test results and patient anthropometric data to generate detailed reports which provides valuable insights into patient general liver condition.
- Total Bilirubin
- GGT
- ALT
- AST
- Fasting Glucose
- Tryglycerides
- Total Cholesterol
How it Works
Physician prescribes
LIVERSTAT
Health Systems Database
Lab analyzes
7 biomarkers from
1 blood draw
Biomarker values plus age,
height, weight, gender, are
entered into the platform
LIVESTAT results
are available
Physician prescribes
LIVERSTAT
Health Systems Database
Lab analyzes
10 biomarkers from
1 blood draw
Biomarker values plus age,
height, weight, gender, are
entered into the platform
LIVERFASt™ results
are available
immediately
What does LIVERSTAT Measure?
LIVERSTAT classifies the presence of presumed steatosis and severity of presumed fibrosis
CLASS
INTERPRETATION
Class A
No presumed liver fibrosis. No presumed steatosis
Class B
Mild fibrosis
Class C
No presumed liver fibrosis. Presumed steatosis
Class D
Presumed liver fibrosis, mild or moderate
Clinical Validation
LIVERSTAT predicts biopsy results, ALT and AST do not
LIVERSTAT outperforms ALT, AST & FIB-4
Integration and Usability
LIVERSTAT seamlessly integrates into any healthcare data systems, enabling automated screening at high scale or one patient at a time by using routine blood work, LIVERSTAT provides high value screening at low cost.
LIVERSTAT is approved in Malaysia
LIVERSTAT is officially approved for use in Malaysia. This approval highlights our dedication to delivering healthcare solutions that prioritize safety and accessibility for patients with our advance medical technology.
Interested in LIVERSTAT?
Sign up with us to receive exclusive brochures and posters that provide detailed insights into our groundbreaking products.
